AHA Coding Clinic® for HCPCS - 2023 Quarter 4; For Your Information
Code Updates for the Prevention of Respiratory Syncytial Virus (RSV)
Code updates for the prevention of respiratory syncytial virus (RSV) On June 30, 2023, the American Medical Association (AMA) released CPT product codes 90380 and 90381 for nirsevimab for the prevention of respiratory syncytial virus (RSV). Nirsevimab is not a vaccine but a monoclonal antibody and is recommend for all infants under eight months of age who are born during or starting into, their first RSV season. It is also recommended for children between 8 and 19 months of age who have an increased risk for RSV infection and are entering into their second RSV season. Also released...
Subscribe or sign in to view the full article.
Article Overview
This article explains recent CPT updates for respiratory syncytial virus (RSV) prevention. It covers AMA-released product and administration coding changes tied to RSV monoclonal antibody and vaccine prevention efforts, along with release and effective dates. The content is relevant for coders, billers, and clinical documentation teams working with infant, pediatric, and maternal preventive RSV services.
Why This Topic Matters
RSV prevention coding changed in 2023, and accurate reporting depends on knowing which CPT codes were introduced and when they became effective. This matters for claims processing, preventive service documentation, and alignment with current AMA guidance.
Article Sections
-
Code updates for the prevention of respiratory syncytial virus (RSV)
Overview of recent CPT changes related to RSV prevention and the organizations involved. Introduces the general categories of product and administration coding addressed in the article.
-
CPT product codes for RSV prevention
Summarizes the newly released CPT product coding discussed for RSV prevention services. Includes the timing of release and effective dates.
-
RSV vaccine product for pregnant patients
Covers the RSV vaccine product discussed in the article and its preventive context. Notes the associated release and effective timing information.
-
CPT administration codes for RSV monoclonal antibodies
Addresses the administration coding updates for RSV monoclonal antibody services. Includes the related release and effective dates noted in the article.
What You Will Learn
- What recent CPT updates were released for RSV prevention
- How the article distinguishes between product and administration coding changes
- Which organizations and timeframes are associated with the updates
- What general preventive service categories are covered in the guidance
Who Should Read This
- Medical coders
- Billers and revenue cycle staff
- Clinical documentation specialists
- Pediatric and maternal health practices
- Healthcare reimbursement professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com